The MINIject offers promise as a new supracillary MIGS implant
- Posted on: Jan 28 2022
- Leave a response
The MINIject glaucoma drainage device, composed of a biocompatible porous silicone material, is a novel implant developed to target the suprachoroidal space. Six-month data have been previously published; this study evaluated the efficacy and safety of the MINIject device over a 2-year follow-up period.
Source: AAO
Posted in: Uncategorized
